Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Hoang is an analyst at Deutsche Bank. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/19/2025 | SRPT | Buy Now | Sarepta Therapeutics | $78.92 | 25.44% | David Hoang42% | $124 → $99 | Maintains | Hold | Get Alert |
| 02/11/2025 | XENE | Buy Now | Xenon Pharmaceuticals | $35.04 | 91.21% | David Hoang42% | → $67 | Initiates | → Buy | Get Alert |
| 02/11/2025 | PRAX | Buy Now | Praxis Precision Medicine | $36.82 | 201.47% | David Hoang42% | → $111 | Initiates | → Buy | Get Alert |
| 02/11/2025 | HRMY | Buy Now | Harmony Biosciences | $34.98 | 57.21% | David Hoang42% | → $55 | Initiates | → Buy | Get Alert |
| 02/11/2025 | DNLI | Buy Now | Denali Therapeutics | $14.61 | 112.18% | David Hoang42% | → $31 | Initiates | → Buy | Get Alert |
| 02/11/2025 | BHVN | Buy Now | Biohaven | $28.52 | 127.91% | David Hoang42% | → $65 | Initiates | → Buy | Get Alert |
| 02/11/2025 | AXSM | Buy Now | Axsome Therapeutics | $124.17 | 41.74% | David Hoang42% | → $176 | Initiates | → Buy | Get Alert |
| 02/11/2025 | ALKS | Buy Now | Alkermes | $34.84 | 14.79% | David Hoang42% | → $40 | Initiates | → Buy | Get Alert |
| 02/11/2025 | AVDL | Buy Now | Avadel Pharmaceuticals | $8.55 | 40.35% | David Hoang42% | → $12 | Initiates | → Buy | Get Alert |
| 08/08/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.41 | 32.11% | David Hoang42% | $30 → $23 | Maintains | Buy | Get Alert |
| 08/08/2024 | SRPT | Buy Now | Sarepta Therapeutics | $78.92 | 102.72% | David Hoang42% | $176 → $160 | Maintains | Neutral | Get Alert |
| 08/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $110.22 | 43.35% | David Hoang42% | $150 → $158 | Maintains | Neutral | Get Alert |
| 08/02/2024 | DNLI | Buy Now | Denali Therapeutics | $14.61 | 119.03% | David Hoang42% | $26 → $32 | Maintains | Buy | Get Alert |
| 08/02/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | David Hoang42% | $45 → $50 | Maintains | Buy | Get Alert |
| 07/25/2024 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.30 | 438.46% | David Hoang42% | → $7 | Initiates | → Buy | Get Alert |
| 07/02/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | David Hoang42% | $40 → $45 | Maintains | Buy | Get Alert |
| 06/26/2024 | SRPT | Buy Now | Sarepta Therapeutics | $78.92 | 123% | David Hoang42% | $172 → $176 | Downgrade | Buy → Neutral | Get Alert |
| 06/21/2024 | HRMY | Buy Now | Harmony Biosciences | $34.98 | 37.2% | David Hoang42% | → $48 | Initiates | → Buy | Get Alert |
| 05/29/2024 | SAGE | Buy Now | Sage Therapeutics | $8.01 | -0.06% | David Hoang42% | → $8 | Initiates | → Sell | Get Alert |
| 05/10/2024 | XENE | Buy Now | Xenon Pharmaceuticals | $35.04 | 71.23% | David Hoang42% | $62 → $60 | Maintains | Buy | Get Alert |
| 05/09/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.41 | 72.31% | David Hoang42% | $30.19 → $30 | Maintains | Buy | Get Alert |
| 05/07/2024 | AXSM | Buy Now | Axsome Therapeutics | $124.17 | 0.67% | David Hoang42% | $127 → $125 | Maintains | Buy | Get Alert |
| 05/03/2024 | NBIX | Buy Now | Neurocrine Biosciences | $110.22 | 36.09% | David Hoang42% | $140 → $150 | Maintains | Neutral | Get Alert |
| 03/26/2024 | AXSM | Buy Now | Axsome Therapeutics | $124.17 | 2.28% | David Hoang42% | $125 → $127 | Maintains | Buy | Get Alert |
| 03/15/2024 | SLDB | Buy Now | Solid Biosciences | $4.66 | 243.35% | David Hoang42% | → $16 | Initiates | → Buy | Get Alert |
| 03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.41 | 73.41% | David Hoang42% | $38 → $30.19 | Maintains | Buy | Get Alert |
| 03/07/2024 | VYGR | Buy Now | Voyager Therapeutics | $3.95 | 305.06% | David Hoang42% | → $16 | Initiates | → Buy | Get Alert |
| 02/29/2024 | SRPT | Buy Now | Sarepta Therapeutics | $78.92 | 117.93% | David Hoang42% | $160 → $172 | Maintains | Buy | Get Alert |
| 02/16/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | David Hoang42% | → $40 | Initiates | → Buy | Get Alert |
| 02/08/2024 | NBIX | Buy Now | Neurocrine Biosciences | $110.22 | 27.02% | David Hoang42% | $141 → $140 | Maintains | Neutral | Get Alert |
| 01/04/2024 | XENE | Buy Now | Xenon Pharmaceuticals | $35.04 | 76.94% | David Hoang42% | → $62 | Initiates | → Buy | Get Alert |
| 12/13/2023 | DNLI | Buy Now | Denali Therapeutics | $14.61 | 119.03% | David Hoang42% | → $32 | Initiates | → Buy | Get Alert |
| 12/13/2023 | NBIX | Buy Now | Neurocrine Biosciences | $110.22 | 15.22% | David Hoang42% | → $127 | Initiates | → Neutral | Get Alert |
| 12/13/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.41 | 118.27% | David Hoang42% | → $38 | Initiates | → Buy | Get Alert |
| 12/13/2023 | SRPT | Buy Now | Sarepta Therapeutics | $78.92 | 43.17% | David Hoang42% | → $113 | Initiates | → Buy | Get Alert |
| 12/13/2023 | AXSM | Buy Now | Axsome Therapeutics | $124.17 | 0.67% | David Hoang42% | → $125 | Initiates | → Buy | Get Alert |
| 04/26/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $248.20 | -11.36% | David Hoang42% | → $220 | Initiates | → Neutral | Get Alert |
| 04/26/2023 | ARWR | Buy Now | Arrowhead Pharma | $15.15 | 427.88% | David Hoang42% | → $80 | Initiates | → Outperform | Get Alert |
| 04/26/2023 | SRPT | Buy Now | Sarepta Therapeutics | $78.92 | 134.4% | David Hoang42% | → $185 | Initiates | → Outperform | Get Alert |
| 03/14/2023 | PRVB | Buy Now | Provention Bio | — | — | David Hoang42% | $15 → $25 | Downgrade | Outperform → Neutral | Get Alert |
| 12/07/2022 | GOSS | Buy Now | Gossamer Bio | $1.33 | 124.72% | David Hoang42% | → $3 | Downgrade | Outperform → Neutral | Get Alert |
| 04/01/2022 | ORTX | Buy Now | Orchard Therapeutics | — | — | David Hoang42% | — | Downgrade | Outperform → Neutral | Get Alert |
